Blog Template

/Blog Template/

QuarryBio (formerly ReclaimRx) Announces Dr. John Hale as new CSO

QuarryBio (formerly named ReclaimRx) is pleased to announce that Dr. John Hale has accepted the role of Chief Scientific Officer (CSO). In this role, John will oversee the technical program for QuarryBio. “John brings a lengthy list of experience and accomplishments to this role, and his presence and direction will greatly enhance our ability to [...]

By | 2017-02-02T19:08:43+00:00 January 26th, 2017|News|0 Comments

QuarryBio (formerly ReclaimRx) characterizes α-synuclein for Parkinson’s disease research for Michael J Fox Foundation

QuarryBio (formerly named ReclaimRx) is pleased to announce the successful completion of a quality assurance project performed for The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to evaluate the quality and identity of semi-synthetic α-synuclein supplied for Parkinson’s disease research. α-synuclein is thought to play a significant role in the onset and progression of [...]

By | 2017-02-02T19:08:50+00:00 July 31st, 2012|News|0 Comments

ReclaimRx LLC Wins Technology Commercialization Grant

QuarryBio (operating as ReclaimRx, LLC) was one of two winners in the Leon County Research & Development Authority’s annual technology commercialization grant competition in Tallahassee, FL on May 14, 2014. The company received $15,000 in funding to finish development of the data analysis software to accompany a covalent labeling kit that researchers can use in the lab for protein studies [...]

By | 2017-02-02T19:08:56+00:00 July 31st, 2012|News|0 Comments